Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth

SAP: Prelim. FY15 results at the high-end of company guidance, FY16 guidance almost in line

NEUTRAL, Fair Value EUR75 (+6%)

Published last January Tuesday 12, 2016

Innate Pharma: Out-licensing deal with Sanofi and in-licensing with OREGA Biotech

BUY, Fair Value EUR19 (+48%)

Published last January Monday 11, 2016

Carlsberg: Things are going to get worse before they get better. Downgrade to sell.

SELL vs. NEUTRAL, Fair Value DKK485 vs. DKK519 (-18%)

Published last January Monday 11, 2016

Casino Guichard: FIRST TAKE COMMENT: a guidance engraved in stone

BUY, Fair Value EUR69 (+57%)

Published last December Monday 21, 2015

Celyad: CHART-2 cleared by the FDA

BUY, Fair Value EUR81 vs. EUR71 (+75%)

Published last December Monday 21, 2015

Be ready for the upcoming takeover bid on Gameloft (hostile or friendly)!

BUY, Fair Value EUR6.7 (+12%)

Published last December Monday 21, 2015

Casino Guichard: Slander as much as you like! There will always be something left!

BUY, Fair Value EUR69 (+59%)

Published last December Friday 18, 2015

ELIOR: FY results First take: Slightly better

BUY, Fair Value EUR20 (+15%)

Published last December Friday 11, 2015

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities